Highly-focused R&D personnel and programmes enable us to anticipate and respond to the needs of a rapidly-changing animal health industry.

Merial's R&D benefits from full access to the extensive research resources of our parent companies (Merck & Co. Inc, and Aventis S.A.)- two of the world's leading life science companies.


PIPELINE

One of Merial's most powerful resources is its rich and exciting pipeline on which the company's strength and future growth are being built.

Merial's research philosophy emphasises the development of new products to enhance the health and performance of all livestock and companion animal species and to protect against parasitic, enteric and respiratory diseases in bovine, porcine and companion animal species.

Research programmes specifically dedicated to avian species are also in development.


EPIDEMIOLOGICAL SURVEILLANCE

Merial is commited to effective epidemiological surveillance. By helping to develop and enforce international policies and regulations regarding animal health and welfare, Merial actively participates in the fight against major epidemics throughout the world. When new strains of viruses appear, Merial research teams react rapidly and effectively, developing the powerful new vaccines needed to fight them.